Titlebook: Lupus Erythematosus; Clinical Evaluation Peter H. Schur,Elena M. Massarotti Book 2012 Springer Science+Business Media New York 2012 ANA.Er

娛樂某人

書目名稱Lupus Erythematosus影響因子(影響力)




書目名稱Lupus Erythematosus影響因子(影響力)學科排名




書目名稱Lupus Erythematosus網(wǎng)絡公開度




書目名稱Lupus Erythematosus網(wǎng)絡公開度學科排名




書目名稱Lupus Erythematosus被引頻次




書目名稱Lupus Erythematosus被引頻次學科排名




書目名稱Lupus Erythematosus年度引用




書目名稱Lupus Erythematosus年度引用學科排名




書目名稱Lupus Erythematosus讀者反饋




書目名稱Lupus Erythematosus讀者反饋學科排名

BRAND

The Immunopathogenesis and Immunopathology of Systemic Lupus Erythematosus,es can bind protein and nucleic acid components of the cell nucleus to form immune complexes to drive pathogenesis. These complexes can deposit in the kidney to incite nephritis or stimulate plasmacytoid dendritic cells (pDCs) to produce cytokines, most prominently type 1 interferon. The activity of

牌帶來

Diagnosing and Monitoring Lupus,affect virtually every organ. The most common pattern is a mixture of constitutional complaints with skin, musculoskeletal, hematologic, and serologic involvement (show Table 3.1). However, some patients have predominately hematologic, renal, cardiopulmonary, or central nervous system manifestations

艱苦地移動

Recommendations on How to Monitor the Patient with Systemic Lupus Erythematosus in the Clinic or atow patients with SLE in the clinic when the disease is mild to moderate and or well controlled. At times patients with SLE are hospitalized and are monitored much more intensively according to extent of their disease activity. In clinical studies investigators frequently use complex outcome measures

chisel

Laconic

Musculoskeletal Manifestations of SLE,iness either at the onset of the disease or later during its course. Yet the frequency of arthralgia or arthritis in lupus populations is quiet variable; for example, in one series described by Fries, it was observed in 53 % of 193 patients, and in the Dubois series, it was described at some time du

箴言

不可比擬

緯線

Hematologic Manifestations of SLE,o provide an overview of potential hematologic complications of SLE, with a focus on the prognostic significance, pathophysiology, workup, and treatment options for lupus-associated anemia, thrombocytopenia, immunological defects, and coagulopathies.

watertight,